Document ID: chunk:federal_register_of_legislation:F2017L00008:reg:7
Version: federal_register_of_legislation:F2017L00008
Segment Type: reg
Provision Reference: reg 7
Character Range: 1608–3125

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about relapsing polychondritis and death from relapsing polychondritis.
Meaning of relapsing polychondritis
(2)          For the purposes of this Statement of Principles, relapsing polychondritis means a systemic autoimmune disease characterised by episodic, progressive inflammatory destruction of cartilaginous structures and connective tissue throughout the body, predominantly affecting the ears, nose, eyes, joints and respiratory tract.
(3)          While relapsing polychondritis attracts ICD‑10‑AM code M94.1, in applying this Statement of Principles the meaning of relapsing polychondritis is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD‑10‑AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD‑10‑AM), Ninth Edition, effective date of 1 July 2015, copyrighted by the Independent Hospital Pricing Authority, ISBN 978‑1‑76007‑020‑5.
Death from relapsing polychondritis
(5)          For the purposes of this Statement of Principles, relapsing polychondritis, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's relapsing polychondritis.
Note: terminal event is defined in the Schedule 1 – Dictionary.